Euan Ashley, professor of medicine and genetics, tells the stories of his patients with rare or mystery diseases through his new book, The Genome Odyssey.
Category: Genetics
Less is more? Focused genetic testing recommended for breast and ovarian cancers
Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.
Take heed: Turn to the experts to interpret pharmacogenetic tests
In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.
Concussion: Could your genes increase your risk?
Stanford scientists have found two genes associated with concussion. Screening football players and military might identify those at higher risk.
Stanford Medicine researchers work to stop COVID-19
Stanford Medicine researchers are investigating SARS-CoV-2 to address the COVID-19 pandemic and ultimately help restore normalcy to society.
When a child’s quality of life outweighs the next test or procedure
A Stanford researcher talks about navigating the uncertainty of making medical decisions for her 5-year-old son with an undiagnosed genetic disorder.
How does 2020 Nobel Prize-winning CRISPR technology work?
The 2020 Nobel Prize in Chemistry recognized the scientists who developed the CRISPR-Cas9 gene-editing technology. Here's how it's changing medicine.
Post-surgical abdominal adhesions: A potential cause and possible treatment
Abdominal adhesions frequently occur after abdominal surgery. Stanford researchers prevented their formation in mice by blocking a molecular pathway.
An ancient virus might have made our hearts bigger
A Stanford-led study finds that remnants of an ancient viral infection may be the reason humans and other primates evolved to have larger hearts and bodies.
Genetic edit protects against transplanted cells that go rogue
Stanford researchers and colleagues have invented a genetic safety mechanism that can deactivate transplanted cells if they change in a problematic way.
Seeking a less-burdensome treatment for Diamond Blackfan anemia
Stanford researchers have found a good drug target for treating Diamond-Blackfan anemia, a genetic disease that impairs red blood cell formation.
New evidence suggests early metastasis is common in lung and breast cancers
In breast and lung cancer patients with metastatic disease, seeds of metastasis were often planted before the primary tumor was diagnosed, a study finds.
Analyzing patients’ tumors, from the inside out
The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
3D lung cancer “spheroids” reveal hidden drivers of disease
Scientists create a new 3D lung cancer model to better reveal the drivers of cancer, and in doing so, find a new gene that may be a possible drug target.
Stanford technology helps advance CRISPR-based cancer therapy
A team led by Howard Chang has contributed key technology to enable new experimental cancer therapy that uses CRISPR to edit immune cells.
Study sheds light on the genetics of hibernation
Researchers zeroed in on the genes driving ground squirrel hibernation — and their insights could be helpful for understanding human health.